Anti-counterfeiting and traceability method, device and system for bottled medicines based on micro-dot codes

Abstract

The present invention provides an anti-counterfeiting and traceability method, device and system for bottled medicines based on microdot codes, the method comprising: determining a labeling gap threshold according to the outer diameter of the medicine bottle; determining the minimum readable side length of the microdot code according to the outer diameter of the medicine bottle; setting the bottle label to fixedly wrap the outer wall of the medicine bottle so that the labeling gap of the bottle label is less than or equal to the labeling gap threshold, the bottle label is printed with the microdot code for anti-counterfeiting and traceability, the long side length of the microdot code is equal to the long side length of the bottle label, and the short side length is greater than or equal to the minimum readable side length. The present invention can solve the problem of difficulty in data collection for each bottle of medicine on the production line, realize single medicine traceability, and realize that the source and destination of the medicine can be checked.

Description

Technical Field

[0001] The present invention relates to the field of anti-counterfeiting technology, and in particular to an anti-counterfeiting tracing method, device and system for bottled medicines based on micro-dot codes. Background Art

[0002] At present, the information identification carriers used for drug traceability are barcodes and QR codes, such as drug electronic supervision codes, GS1 standard QR codes, DM codes, etc. Barcodes and QR codes are used for drug traceability, and are currently only widely used in carton packaging, large-volume bottle labels, outer box labels, etc. Due to the difficulty in implementing automated collection on production lines, the application rate of single-dose traceability of small-volume bottled drugs such as ampoules and vials is not high, resulting in slow progress in single-dose traceability of domestic drugs, which poses risks to drug safety traceability and control.

[0003] To trace the source of drugs, it is necessary to collect data for each bottle of drugs on the production line of the pharmaceutical factory, and associate and bind each level of packaging from small to large. However, since the outer diameter of the bottle of drugs in ampoules and vials is small and the curvature is large, it has a great impact on the collection of barcodes, QR codes, DM codes, etc., and the collection success rate is low.

[0004] In actual production, the traceability codes of medicine bottles are oriented in different directions after they travel on the assembly line or are loaded into pallets. In addition, barcodes and QR codes cannot achieve 360-degree data automatic collection in the scenarios of ampoules and vials. Data collection is difficult to implement, and the automation transformation of production lines is large, the cost of technical transformation is high, and the collection effect is poor. Summary of the invention

[0005] The purpose of the embodiments of the present invention is to provide an anti-counterfeiting and traceability method, device and system for bottled medicines based on micro-dot codes, which can solve the problem of difficulty in collecting data for each bottle of medicine on the production line, realize the traceability of individual medicines, and realize that the source and destination of the medicines can be checked.

[0006] In order to achieve the above-mentioned purpose, an embodiment of the present invention provides an anti-counterfeiting and traceability method for bottled medicines based on micro-dot codes, the method comprising: determining a labeling gap threshold according to an outer diameter of the medicine bottle; determining a minimum readable side length of the micro-dot code according to the outer diameter of the medicine bottle; setting the bottle label to fixedly wrap the outer wall of the medicine bottle so that the labeling gap of the bottle label is less than or equal to the labeling gap threshold, the bottle label is printed with the micro-dot code for anti-counterfeiting and traceability, the long side length of the micro-dot code is equal to the long side length of the bottle label, and the short side length is greater than or equal to the minimum readable side length.

[0007] Preferably, determining the labeling gap threshold according to the outer diameter of the medicine bottle includes: determining the circumference of the outer diameter of the medicine bottle according to the outer diameter of the medicine bottle; when the circumference of the outer diameter of the medicine bottle is less than or equal to 50 mm, the labeling gap threshold is less than or equal to 2 mm; when the circumference of the outer diameter of the medicine bottle is greater than 50 mm, the labeling gap threshold is less than or equal to 5 mm.

[0008] Preferably, determining the minimum readable side length of the micro-dot code based on the outer diameter of the medicine bottle includes: calculating 15% of the outer diameter of the medicine bottle as the minimum readable side length of the micro-dot code.

[0009] Preferably, the medicine bottle is an ampoule or a vial.

[0010] Preferably, the minimum readable side length of the micro-dot code is 1.5 mm.

[0011] An embodiment of the present invention also provides an anti-counterfeiting and traceability device for bottled medicines based on micro-dot codes, the device comprising: a gap determination unit, a side length determination unit and a bottle label setting unit, wherein the gap determination unit is used to determine a labeling gap threshold according to an outer diameter of the medicine bottle; the side length determination unit is used to determine a minimum readable side length of the micro-dot code according to the outer diameter of the medicine bottle; the bottle label setting unit is used to set the bottle label to fixedly wrap the outer wall of the medicine bottle so that the labeling gap of the bottle label is less than or equal to the labeling gap threshold, the bottle label is printed with the micro-dot code for anti-counterfeiting and traceability, the long side length of the micro-dot code is equal to the long side length of the bottle label, and the short side length is greater than or equal to the minimum readable side length.

[0012] Preferably, the gap determination unit is used to: determine the circumference of the outer diameter of the medicine bottle based on the outer diameter of the medicine bottle; when the circumference of the outer diameter of the medicine bottle is less than or equal to 50 mm, the labeling gap threshold is less than or equal to 2 mm; when the circumference of the outer diameter of the medicine bottle is greater than 50 mm, the labeling gap threshold is less than or equal to 5 mm.

[0013] Preferably, the side length determination unit is used to calculate 15% of the outer diameter of the medicine bottle as the minimum readable side length of the micro-dot code.

[0014] An embodiment of the present invention also provides an anti-counterfeiting and traceability system for bottled medicines based on micro-dot codes, the system comprising: a medicine bottle labeled with the anti-counterfeiting and traceability method for bottled medicines based on micro-dot codes as described above; a medicine bottle container for containing the medicine bottle; multiple collection devices, arranged in multiple directions, for collecting information of the micro-dot code on the medicine bottle, and binding the code value of the micro-dot code with the production traceability information; a printing device, for printing a traceability code on the medicine bottle container, the traceability code corresponding to the micro-dot code on the medicine bottle.

[0015] Through the above technical scheme, the embodiment of the present invention provides an anti-counterfeiting and traceability method, device and system for bottled medicines based on micro-dot codes. The micro-dot codes are used to overcome the influence of the curved surface of the medicine bottles, and the labeling gap is controlled and a multi-view acquisition device is set to realize full-range readability of the medicine bottles. The problem of difficulty in collecting data for each bottle of medicine on the production line can be solved, and the single-drug traceability can be realized, so that the source and destination of the medicines can be checked.

[0016] Other features and advantages of the embodiments of the present invention will be described in detail in the subsequent detailed description. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] The accompanying drawings are used to provide a further understanding of the embodiments of the present invention and constitute a part of the specification. Together with the following specific implementations, they are used to explain the embodiments of the present invention, but do not constitute a limitation on the embodiments of the present invention. In the accompanying drawings:

[0018] Figure 1 It is a flow chart of an anti-counterfeiting and traceability method for bottled medicines based on micro-dot codes provided by an embodiment of the present invention;

[0019] Figure 2 is a labeling schematic diagram provided by an embodiment of the present invention;

[0020] Figure 3 is a flow chart of a method for determining a labeling gap threshold provided by an embodiment of the present invention;

[0021] Figure 4 This is a schematic diagram of the distribution of two-dimensional codes provided by an embodiment of the present invention;

[0022] Figure 5 It is a structural block diagram of an anti-counterfeiting and traceability device for bottled medicines based on micro-dot codes provided by an embodiment of the present invention;

[0023] Figure 6 It is a schematic diagram of an anti-counterfeiting and traceability system for bottled medicines based on microdot codes provided in one embodiment of the present invention.

[0024] Description of Reference Numerals

[0025] 1-gap determination unit, 2-side length determination unit, 3-bottle label setting unit DETAILED DESCRIPTION

[0026] The specific implementation of the embodiment of the present invention is described in detail below in conjunction with the accompanying drawings. It should be understood that the specific implementation described here is only used to illustrate and explain the embodiment of the present invention, and is not used to limit the embodiment of the present invention.

[0027] Figure 1 FIG. 1 is a flow chart of a method for anti-counterfeiting and traceability of bottled medicines based on microdot codes provided by an embodiment of the present invention. Figure 1As shown, the method includes:

[0028] Step S101, determining a labeling gap threshold according to the outer diameter of the medicine bottle;

[0029] Specifically, the medicine bottle can be a very small medicine bottle such as an ampoule or a vial. Figure 2 As shown in the figure, after the bottle label is attached to the medicine bottle, there will be a labeling gap at both ends of the bottle label. In order to ensure that there is enough micro-dot code readable unit area in the exposed area of ​​the bottle label for the industrial camera to collect and improve the collection efficiency, the labeling gap should be controlled within a certain range, that is, the designed bottle label size should be within a certain range.

[0030] Therefore, the embodiment of the present invention provides an implementation method of this step as follows: Figure 3 As shown, but not limited to this. Those skilled in the art should understand that 50mm, 2mm and 5mm are only preferred values, which will be adjusted as the medicine bottle changes:

[0031] Step S301, determining the circumference of the outer diameter of the medicine bottle according to the outer diameter of the medicine bottle;

[0032] Step S302, determining whether the outer diameter circumference of the medicine bottle is less than or equal to 50 mm;

[0033] Step S303, when the outer diameter circumference of the medicine bottle is less than or equal to 50 mm, the labeling gap threshold is less than or equal to 2 mm;

[0034] Step S304: when the outer diameter circumference of the medicine bottle is greater than 50 mm, the labeling gap threshold is less than or equal to 5 mm.

[0035] Step S102, determining the minimum readable side length of the micro-dot code according to the outer diameter of the medicine bottle;

[0036] Specifically, the micro-dot code is a closed encoding and decoding algorithm. The code image cannot be read by other open source code decoding algorithms. Compared with the traditional dense two-dimensional code that converts code values ​​into binary 1 and 0 and arranges them in the form of deep and shallow code points respectively, the code value of the micro-dot code is converted into binary data with an obvious gap greater than or equal to 1 data position, and the code value can be a string of any character encoding.

[0037] The random additional dot graphic security code physical identification made with micro-dot code supports more than 90% robustness within 20mm*20mm, supports decoding even if it is damaged to any remaining 3mm*3mm complete area, still has 15% fault tolerance within the minimum readable area of ​​3mm*3mm, and supports reading under interference patterns other than linear, lumpy, and shaped code points. The dot matrix code system that meets this robustness condition provides a strong guarantee for embedding anti-counterfeiting features with sufficient quantity, area, and position independence.

[0038] In the embodiment of the present invention, 15% of the outer diameter of the medicine bottle is calculated as the minimum readable side length of the micro-dot code. Preferably, the minimum readable side length of the micro-dot code is 1.5 mm. However, those skilled in the art should understand that the above 15% and 1.5 mm are only preferred values, which can be adjusted according to actual conditions when the micro-dot code is readable.

[0039] Step S103, setting the bottle label to fix and wrap the outer wall of the medicine bottle so that the labeling gap of the bottle label is less than or equal to the labeling gap threshold, the bottle label is printed with the micro-dot code for anti-counterfeiting traceability, the long side length of the micro-dot code is equal to the long side length of the bottle label, and the short side length is greater than or equal to the minimum readable side length.

[0040] Specifically, the above text determines the bottle label size and the layout of the micro-dot code on the bottle label based on the specifications and dimensions of the drug bottle and the micro-dot code reading characteristics. In the embodiment of the present invention, in order to solve the problem that the traceability code cannot be collected because the drug bottles are oriented in different directions on the production line and are not within the field of view of the industrial camera, the layout of the micro-dot code on the bottle label is to cover the entire bottle label or partially surround the bottle label in the radial direction of the bottle body, such as Figure 4 As shown, no matter how the medicine bottle is oriented, there will always be a readable unit of the micro-dot code within the field of view of the industrial camera. In particular, in order to avoid the influence of the graphic content on the micro-dot code acquisition, there is a coding area with a short side length greater than or equal to the minimum readable side length in the radial direction of the bottle body, which surrounds the bottle label without other graphic content.

[0041] After setting up like this, you can print micro-dot codes and labels accordingly, and you can generate micro-dot code images in batches through special generation software technology. Using micro-dot codes as the traceability carrier for a single bottle of medicine, micro-dot codes are one-to-one codes, which can satisfy the requirement of giving each bottle label a unique ID. In addition, micro-dot codes have the characteristics of small readable unit area, multiple reading units forming a code map, and decoding can be completed by reading any reading unit. This can overcome the influence of the large curvature of the bottle, and is particularly suitable for the collection of ampoules and vials of small bottles of medicine.

[0042] Figure 5 FIG. 1 is a structural block diagram of an anti-counterfeiting and traceability device for bottled medicines based on micro-dot codes provided by an embodiment of the present invention. Figure 5As shown, the device includes: a gap determination unit 1, a side length determination unit 2 and a bottle label setting unit 3, wherein the gap determination unit 1 is used to determine the labeling gap threshold according to the outer diameter of the medicine bottle; the side length determination unit 2 is used to determine the minimum readable side length of the micro-dot code according to the outer diameter of the medicine bottle; the bottle label setting unit 3 is used to set the bottle label to fix and wrap the outer wall of the medicine bottle so that the labeling gap of the bottle label is less than or equal to the labeling gap threshold, the bottle label is printed with the micro-dot code for anti-counterfeiting traceability, the long side length of the micro-dot code is equal to the long side length of the bottle label, and the short side length is greater than or equal to the minimum readable side length.

[0043] Preferably, the gap determination unit 1 is used to: determine the circumference of the outer diameter of the medicine bottle according to the outer diameter of the medicine bottle; when the circumference of the outer diameter of the medicine bottle is less than or equal to 50 mm, the labeling gap threshold is less than or equal to 2 mm; when the circumference of the outer diameter of the medicine bottle is greater than 50 mm, the labeling gap threshold is less than or equal to 5 mm.

[0044] Preferably, the side length determination unit 2 is used to calculate 15% of the outer diameter of the medicine bottle as the minimum readable side length of the micro-dot code.

[0045] Preferably, the medicine bottle is an ampoule or a vial.

[0046] Preferably, the minimum readable side length of the micro-dot code is 1.5 mm.

[0047] The anti-counterfeiting and traceability device for bottled medicines based on micro-dot codes described above is similar to the embodiment of the anti-counterfeiting and traceability method for bottled medicines based on micro-dot codes described above, and will not be repeated here.

[0048] Figure 6 FIG. 1 is a schematic diagram of an anti-counterfeiting and traceability system for bottled medicines based on micro-dot codes provided by an embodiment of the present invention. Figure 6 As shown, the system includes: a medicine bottle labeled with the anti-counterfeiting and traceability method for bottled medicines based on micro-dot codes as described above; a medicine bottle container for containing the medicine bottle; multiple collection devices, arranged in multiple directions, for collecting information of the micro-dot code on the medicine bottle, and binding the code value of the micro-dot code with the production traceability information; a printing device, for printing a traceability code on the medicine bottle container, and the traceability code corresponds to the micro-dot code on the medicine bottle.

[0049] Specifically, in order to ensure the accuracy of the collected data and the correspondence of the associated binding, the embodiment of the present invention particularly preferably adopts the whole-tray collection method to collect bottle label data. That is, after the medicines are loaded into the medicine bottle container (such as a pallet) (5 bottles / tray, 10 bottles / tray or other specifications), multiple collection devices, such as micro-dot code data collection industrial cameras, are installed directly above the production line to automatically collect the micro-dot code data on all the medicine bottle labels in the tray at one time. Particularly preferably, in order to solve the problem of extreme label gaps facing directly above and improve the collection success rate, three cameras are used in the micro-dot code data collection industrial camera device and the installation directions are different (one facing directly below, one facing the lower right, and one facing the lower left), thereby increasing the collection field of view of the industrial camera device and avoiding blind spots. Although the orientation of the medicine bottle cannot be accurately controlled when loading the tray, the orientation is different, but through the design of the micro-dot code full circle coding area in the first step above and the characteristics of the micro-dot code extremely small readable unit, no matter how the medicine bottle is oriented, there are always enough readable units to be captured and recognized by the industrial camera directly above.

[0050] When all the bottle label micro-dot codes in the pallet are successfully collected, the collection industrial control system will activate these bottle label codes and bind them to the preset production traceability information (such as product name, batch number, production date, production line, production team, etc.). At the same time, the industrial control system will generate a pallet code data associated with the bottle label micro-dot code in the pallet, and send it to the printing device behind the bottle label collection station (including but not limited to inkjet printers and laser machines). The printing device will then print the pallet code on the pallet or on the sealing film after the pallet is sealed in the form of a QR code, barcode, DM code, micro-dot code or other traceability code. At this point, the data collection of the drug bottle label is completed and associated with the pallet. When the bottle label data in the pallet is not completely collected successfully, it is processed by automatic rejection or manual rejection with early warning and line stop to ensure that the drugs flowing into the next process have been successfully collected.

[0051] In addition, an industrial camera can also be installed on the existing cartoning machine for pallets in the pharmaceutical factory. At the moment when the pallet is about to be boxed, the above-mentioned printed pallet code and the electronic supervision code of the corresponding medicine box can be collected to complete the association and binding of the pallet and the medicine box, so as to accurately know which pallets are in a certain box of medicine and which bottles of medicine are contained.

[0052] Continuing, according to the existing drug traceability process and hardware and software equipment facilities of the pharmaceutical factory, the subsequent data collection and association binding of the medicine box, outer box, and stack are completed, which will not be repeated here. After the entire batch production is completed, the association relationship data of the packaging traceability code at all levels and the relevant production traceability data are uploaded to the national unified drug traceability supervision platform. So far, all the work of the drug production collection and association link in the pharmaceutical factory has been completed. The present invention solves the problem of difficulty in data collection of small bottles of drugs such as ampoules and vials, and realizes the completion of the association binding of bottle-tray-medicine box-outer box-stack from the original completion of the association binding of medicine box-outer box-stack, so that in the drug traceability, it is known which stack or box of medicine contains which bottles of medicine.

[0053] According to the existing in-and-out warehousing process of the pharmaceutical factory, the above-mentioned completed drugs are put into storage and shipped out, and the in-warehouse data and out-and-out shipping flow data are uploaded to the national unified drug traceability supervision platform. When shipping, it is generally shipped by stack or box. Through the out-of-warehouse data, we can know which stack or which ones are sent to where, and through the multi-level packaging traceability code associated data that has been completed, we can also know which bottle of medicine is sent to where, realizing the change from the original minimum traceability unit of each box to the current minimum traceability unit of each bottle, making drug traceability more refined and accurate, and making drug traceability safer.

[0054] When the medicine has been sent to the hospital, pharmacy or patient, the doctor or patient can trace back the relevant traceability information of the medicine by scanning the micro-dot code on the medicine bottle. When there is a quality problem with the medicine, the relevant regulatory authorities can also trace the production batch and other traceability information of the medicine by scanning the micro-dot code on the bottle label, and can trace to where the same batch of products has been sent, so as to quickly and accurately recall the product.

[0055] Those skilled in the art will appreciate that the embodiments of the present application may be provided as methods, systems, or computer program products. Therefore, the present application may adopt the form of a complete hardware embodiment, a complete software embodiment, or an embodiment in combination with software and hardware. Moreover, the present application may adopt the form of a computer program product implemented in one or more computer-usable storage media (including but not limited to disk storage, CD-ROM, optical storage, etc.) that include computer-usable program code.

[0056] The present application is described with reference to the flowcharts and / or block diagrams of the methods, devices (systems), and computer program products according to the embodiments of the present application. It should be understood that each process and / or box in the flowchart and / or block diagram, as well as the combination of the processes and / or boxes in the flowchart and / or block diagram, can be implemented by computer program instructions. These computer program instructions can be provided to a processor of a general-purpose computer, a special-purpose computer, an embedded processor, or other programmable data processing device to generate a machine, so that the instructions executed by the processor of the computer or other programmable data processing device generate instructions for implementing the processes in the flowchart and / or block diagram. Figure 1 A process or multiple processes and / or boxes Figure 1 A device that provides the functions specified in a block or multiple blocks.

[0057] These computer program instructions may also be stored in a computer-readable memory capable of directing a computer or other programmable data processing device to operate in a specific manner, so that the instructions stored in the computer-readable memory produce an article of manufacture comprising an instruction device, which implements the process Figure 1 A process or multiple processes and / or boxes Figure 1 A function specified in one or more boxes.

[0058] These computer program instructions can also be loaded onto a computer or other programmable data processing device so that a series of operating steps are executed on the computer or other programmable device to produce a computer-implemented process, thereby providing instructions for implementing the process. Figure 1 A process or multiple processes and / or boxes Figure 1 The steps for the functions specified in one or more boxes.

[0059] In a typical configuration, a computing device includes one or more processors (CPU), input / output interfaces, network interfaces, and memory.

[0060] The memory may include non-permanent memory in a computer-readable medium, random access memory (RAM) and / or non-volatile memory in the form of read-only memory (ROM) or flash RAM. The memory is an example of a computer-readable medium.

[0061] Computer readable media include permanent and non-permanent, removable and non-removable media that can be implemented by any method or technology to store information. Information can be computer readable instructions, data structures, program modules or other data. Examples of computer storage media include, but are not limited to, phase change memory (PRAM), static random access memory (SRAM), dynamic random access memory (DRAM), other types of random access memory (RAM), read-only memory (ROM), electrically erasable programmable read-only memory (EEPROM), flash memory or other memory technology, compact disk read-only memory (CD-ROM), digital versatile disk (DVD) or other optical storage, magnetic cassettes, magnetic tape magnetic disk storage or other magnetic storage devices or any other non-transmission media that can be used to store information that can be accessed by a computing device. As defined herein, computer readable media does not include temporary computer readable media (transitory media), such as modulated data signals and carrier waves.

[0062] It should also be noted that the terms "include", "comprises" or any other variations thereof are intended to cover non-exclusive inclusion, so that a process, method, commodity or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, commodity or device. In the absence of more restrictions, the elements defined by the sentence "comprises a ..." do not exclude the existence of other identical elements in the process, method, commodity or device including the elements.

[0063] The above are only embodiments of the present application and are not intended to limit the present application. For those skilled in the art, the present application may have various changes and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application should be included within the scope of the claims of the present application.

Claims

1. An anti-counterfeiting and traceability method for bottled medicines based on micro-dot codes, characterized in that: The method comprises: According to the outer diameter of the medicine bottle, determine the circumference of the outer diameter of the medicine bottle; When the outer diameter circumference of the medicine bottle is less than or equal to the outer diameter circumference setting value, determine that the labeling gap threshold is less than or equal to the first labeling gap setting value; when the outer diameter circumference of the medicine bottle is greater than the outer diameter circumference setting value, determine that the labeling gap threshold is less than or equal to the second labeling gap setting value, and the labeling gap threshold is the uncontacted portion at both ends when a bottle label is attached to the medicine bottle; The minimum readable side length of the micro-dot code is obtained by multiplying the outer diameter of the medicine bottle by a set percentage; The bottle label is arranged to fix and wrap the outer wall of the medicine bottle so that the labeling gap of the bottle label is less than or equal to the labeling gap threshold value, the bottle label is printed with the micro-dot code for anti-counterfeiting traceability, the long side length of the micro-dot code is equal to the long side length of the bottle label, and the short side length is greater than or equal to the minimum readable side length.

2. The anti-counterfeiting and traceability method for bottled medicines based on micro-dot codes according to claim 1 is characterized in that: The outer diameter circumference setting value is 50mm, the first labeling gap setting value is 2mm, and the second labeling gap setting value is 5mm.

3. The anti-counterfeiting and traceability method for bottled medicines based on micro-dot codes according to claim 1 is characterized in that: The set percentage is 15%.

4. The anti-counterfeiting and traceability method for bottled medicines based on micro-dot codes according to claim 1 is characterized in that: The medicine bottle is an ampoule or a vial.

5. The anti-counterfeiting and traceability method for bottled medicines based on micro-dot codes according to claim 3 is characterized in that: The minimum readable side length of the micro-dot code is 1.5 mm. 6.An anti-counterfeiting and traceability device for bottled medicines based on micro-dot codes, characterized in that: The device comprises: A gap determination unit, a side length determination unit and a bottle label setting unit, wherein: The gap determination unit is used for: According to the outer diameter of the medicine bottle, determine the circumference of the outer diameter of the medicine bottle; When the outer diameter circumference of the medicine bottle is less than or equal to the outer diameter circumference setting value, determine that the labeling gap threshold is less than or equal to the first labeling gap setting value; when the outer diameter circumference of the medicine bottle is greater than the outer diameter circumference setting value, determine that the labeling gap threshold is less than or equal to the second labeling gap setting value, and the labeling gap threshold is the uncontacted portion at both ends when a bottle label is attached to the medicine bottle; The side length determination unit is used to obtain the minimum readable side length of the micro-dot code by multiplying the outer diameter of the medicine bottle by a set percentage; The bottle label setting unit is used to set the bottle label to fix and wrap the outer wall of the medicine bottle so that the labeling gap of the bottle label is less than or equal to the labeling gap threshold, the bottle label is printed with the micro-dot code for anti-counterfeiting traceability, the long side length of the micro-dot code is equal to the long side length of the bottle label, and the short side length is greater than or equal to the minimum readable side length.

7. The anti-counterfeiting and traceability device for bottled medicines based on micro-dot codes according to claim 6 is characterized in that: The outer diameter circumference setting value is 50mm, the first labeling gap setting value is 2mm, and the second labeling gap setting value is 5mm.

8. The anti-counterfeiting and traceability device for bottled medicines based on micro-dot codes according to claim 6 is characterized in that: The set percentage is 15%. 9.An anti-counterfeiting and traceability system for bottled medicines based on micro-dot codes, characterized in that: The system includes: A medicine bottle labeled with the anti-counterfeiting and traceability method for bottled medicines based on microdot codes as described in any one of claims 1 to 5; A medicine bottle container, used to hold the medicine bottle; Multiple collection devices are arranged in multiple directions, for collecting information of the micro-dot code on the medicine bottle, and binding the code value of the micro-dot code with the production traceability information; The printing device is used to print a traceability code on the medicine bottle container, and the traceability code is correspondingly associated with the micro-dot code on the medicine bottle.

Images